Furthermore, a deeper clustering of immune cells with the help of novel technology, such as single-cell RNA sequencing [40], using more precise markers, for example, to identify Foxp3+ Treg cells from CD4+ T cells, and in different tumor regions, might provide further insight into the distinct prognostic role of various immune cell subsets in the tumor microenvironment. This evidence concerns the gene FOXP3 and neoplasm.